Out-of-Pocket Expenses for Long-Acting Reversible Contraceptives in Individuals with Employer-Sponsored Insurance
-
By
-
Mikhaila Richards
-
June 16, 2026
Out-of-Pocket Expenses for Long-Acting Reversible Contraceptives
Overview
This report examines the out-of-pocket expenses incurred by individuals with employer-sponsored insurance for long-acting reversible contraceptives (LARC), specifically intrauterine devices (IUDs) and contraceptive implants. Despite the ACA's mandate for cost-free contraceptive coverage, many users still face unexpected costs.
Background
The Affordable Care Act (ACA) requires that contraceptives be provided without cost-sharing, yet many privately insured individuals continue to experience out-of-pocket expenses for LARC. Understanding these costs is crucial for addressing barriers to contraceptive access and ensuring compliance with ACA provisions. This study utilizes a comprehensive claims database to analyze the financial burden on women aged 15-49.
Data Highlights
| Type of Contraceptive | Insertion Encounters |
|---|---|
| IUD | 98,916 |
| Implant | 30,259 |
Key Findings
- Out-of-pocket costs for LARC insertion persist despite ACA mandates.
- 98,916 IUD and 30,259 implant insertion encounters were analyzed.
- Many privately insured individuals face unexpected expenses for LARC services.
- The study highlights ongoing implementation issues regarding contraceptive coverage.
- Access to immediate postpartum or postabortion LARC remains challenging.
Clinical Implications
Healthcare providers should be aware of the potential for out-of-pocket costs associated with LARC, even when covered by insurance. This knowledge can help inform patient counseling and financial planning regarding contraceptive options.
Conclusion
The findings indicate a significant gap between policy mandates and actual patient experiences regarding contraceptive coverage. Addressing these discrepancies is essential for improving access to LARC.
Related Resources & Content
- KFF, Contraception, 2023 -- Out-of-Pocket Expenses for Long-Acting Reversible Contraceptives
- Drugs - Real World Outcomes, 2023 -- An Examination of Out-of-Pocket Expenses for Antipsychotic Medications Among Medicaid Recipients Diagnosed with Schizophrenia
- JAMA Network Open, 2023 -- Out-of-Pocket Costs and Health-Related Social Needs Among Households With Children
- Obesity Surgery, 2023 -- A Comparative Analysis of Roux-en-Y Gastric Bypass and GLP-1 Receptor Agonists Reveals Lower Out-of-Pocket Expenses for Insured Individuals with Type 2 Diabetes and Obesity Over a Two-Year Period
- 45 CFR § 147.130 - Coverage of preventive health services. | Electronic Code of Federal Regulations
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | MMWR
- Frontiers in Reproductive Health — On-site IUD implementation in a student-run free clinic
- 45 CFR § 147.130 - Coverage of preventive health services. | Electronic Code of Federal Regulations (e-CFR) | US Law | LII / Legal Information Institute
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 | MMWR
- Out-of-Pocket Costs for Long-Acting Reversible Contraception Among Individuals Enrolled in Employer Sponsored Insurance Plans - ScienceDirect
Based on findings from:
Out-of-Pocket Costs for Long-Acting Reversible Contraception Among Individuals Enrolled in Employer Sponsored Insurance Plans
Mikhaila Richards. Kaiser Family Foundation, 2026.
https://www.kff.org/womens-health-policy/out-of-pocket-costs-for-long-acting-reversible-contraception-among-individuals-enrolled-in-employer-sponsored-insurance-plans/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.